瘤特异性抗原的表达是癌症免疫编辑的基础
Michel DuPage1, Claire Mazumdar, Leah M Schmidt
1Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
Nature
|February 10, 2012
概括
癌症免疫编辑通过消除敏感细胞来保护瘤. 这项研究表明,淋巴细胞对瘤抗原的识别对编辑至关重要,导致免疫性癌症较少.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 癌症免疫编辑涉及适应性免疫细胞消除正在发展的瘤.
- 瘤细胞可以发展出对免疫攻击的抵抗力,影响癌症的进展.
- 之前的模型由于瘤异质性而面临挑战.
研究的目的:
- 为了研究癌症免疫编辑,使用基因工程土著小鼠模型.
- 为了比较具有相同遗传背景的免疫原和非免疫原瘤.
- 阐明淋巴细胞识别瘤抗原在肉瘤免疫编辑中的作用.
主要方法:
- 利用基因工程小鼠模型用于本土肉瘤生成.
- 在现场监测瘤发病和生长.
- 免疫能力强,免疫缺陷和抗原耐受性小鼠的瘤发育比较.
主要成果:
- 淋巴细胞对瘤特异性抗原的识别对于针对瘤的免疫编辑至关重要.
- 主要的肉瘤被编辑成通过免疫逃避细胞的生长变得不那么免疫性.
- 瘤抗原表达或MHC I呈现的损失足以让免疫系统逃脱.
结论:
- 瘤特异性抗原表达对于免疫监测和潜在的免疫治疗至关重要.
- 免疫编辑选择瘤细胞变体,这些变体逃脱了T淋巴细胞介导的破坏.
- 了解这些机制可以为新的癌症治疗策略提供信息.
相关概念视频
lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


